Your browser doesn't support javascript.
loading
Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies.
Zheng, Dian-Yu; Wang, Yi-Nuo; Huang, Yu-Hong; Jiang, Min; Dai, Cong.
Affiliation
  • Zheng DY; Department of Gastroenterology, First Hospital of China Medical University, Shenyang City, Liaoning Province, China.
  • Wang YN; Department of Gastroenterology, First Hospital of China Medical University, Shenyang City, Liaoning Province, China.
  • Huang YH; Department of Gastroenterology, First Hospital of China Medical University, Shenyang City, Liaoning Province, China.
  • Jiang M; Department of Gastroenterology, First Hospital of China Medical University, Shenyang City, Liaoning Province, China.
  • Dai C; Department of Gastroenterology, First Hospital of China Medical University, Shenyang City, Liaoning Province, China. Electronic address: congdai2006@sohu.com.
Int Immunopharmacol ; 126: 111229, 2024 Jan 05.
Article in En | MEDLINE | ID: mdl-37977068

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Type of study: Systematic_reviews Limits: Humans Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Crohn Disease Type of study: Systematic_reviews Limits: Humans Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2024 Type: Article Affiliation country: China